Table 1.
Reference | Study design | Na | Ageb | Admission BMIc (SD/SE) |
Approach | Start Kcal/day |
Caloric Advancement (Kcal/day)d |
Weight Gain Rate (Kg/wk)e |
IP LOSf, days (SD/SE) |
Rate of RHg |
---|---|---|---|---|---|---|---|---|---|---|
Meal-based Refeeding | ||||||||||
Solanto et al. 1994 | Observational | 22 L 31 H |
16.0 L 16.2 H |
15.0 (1.9) Ah 14.3 (1.6) B |
Meals; behavioral contracts distinguish groups | 1000-1200 | 67-100 (200 q 2-3 days) |
0.64 (0.32) A 1.15 (0.48) B |
≥28 days | NRi |
Arii et al. 1996 | Prospective | 12 | 19.2 | 13.61 | Meals for 1 wk, then one group to oral liquid only for 2-6 wks, then back to meals | 1000 | Variablej | NR | NR | NR |
Ornstein et al. 2003 | Retrospective | 69 | 15.5 | 15.0 (1.5)k | Meals | 1200-1400 | 100-200 (200 q 1-2 days) |
NR | 25.6 (11.6) | 27.5% |
Whitelaw et al. 2010 | Retrospective | 29 | 15.7 | NRl | Target 2200 by day 3, 2700 by day 5 | 1900 | 100-300 | 1.3m | NR | 38% |
Garber et al. 2012 | Observational | 35 | 16.2 | 16.3 (2.3)n | Meals | 1205 | 100 | 0.88 | 16.7 (16.4) | 20% |
Gaudiani et al. 2012 | Retrospective | 25 | 26.0 | 13.1o | Target 2000 kcal/day | 990 | NR | NR | 19 | 45% |
Garber et al. 2013 | Observational | 56 | 16.2 | 15.8 (0.5) Lp 16.6 (0.4) Hq |
Meals | 1093 L 1764 H |
98(6) L 122(8) H |
0.98 L 1.90 H |
17.6 (1.2) L 11.9 (1.0) H |
45% |
Golden et al. 2013 | Retrospective | 310 | 16.1 | 15.9 (2.2) L 16.1 (1.7) Hr |
Meals | 1163 L 1557 H |
100-200 | 1.52 L 1.56 H |
16.6 (9.0) L 13.0 (7.3) H |
18.2% L 14.9% H |
Le Clerc et al. 2013 | Retrospective | 29 | 14.7 | 16.4 (1.7)s | Target weight gain 1 kg/week | 1500 | 75-250 (250 q 2 days) |
1.7 | NR | 3.5% |
El Ghoch et al. 2014 | Prospective | 50 | 26.5 | 15.4 (1.6) | Target weight gain 1-1.5kg/week | 1500 | NR | NRt | 91u | NR |
Redgrave et al. 2015 | Observational | 361 | 28.5 | 16.2 (2.2) | Target 3500-4000kcals/day with IV glucose in BMI<14 |
1200-1500 | 250 (500 q 2-3 days) |
1.98 (0.86) | 27.68 (18.14) | 18.5% |
Combined nasogastric feeding with oral intake | ||||||||||
Bufano et al. 1990 | Retrospective | 9 | NR | NRv | Mean maximum of 2311 kcals/day | NG at 25% of REEw | 25% of target kcals on Day 1, 50% on Day 2, 75% on Day 3 | 1.92 | 9-51x | 33.3% |
Robb et al. 2002 | Retrospective | 52 NG+Oy 48 O |
14.8 NG+O 15.0 O |
15.5 (1.7) NG+O 16.0 (1.8) O |
Compare nocturnal NG + oral to oral; mean maximum kcals: 3255 (NG+O), 2508 (O) | NR | 600, 1080, 1200 on first three days (NG), oral kcals NR | 1.70 NG+O 0.76 O |
22.3 NG+O 22.1 O |
NR |
Silber et al. 2004 | Retrospective | 6 NG+O 8 O |
13.8 NG+O 14.9 O |
15.3 (1.7) NG+O 17.4 (2.3) O |
Compare nocturnal NG + oral to oral; maximum kcals were 4350 (NG+O) and 3400 (O) | NR | 600, 1080, 1200 on first three days (NG), oral kcals NR | 2.12 NG+O 0.53 O |
36.0 NG+O 39.9 O |
NRz |
Riguad et al. 2007 | RCT | 41 NG+O 40 O |
22.5 NG+O 24.2 O |
12.1 (1.5) NG+O 12.8 (2.0) O |
Compare 2-mo NG to NG + oral; target weight gain rate 1 kg/week | Based on REEaa | Variable, to target weight gain rate | 1.36 NG+O 0.88 O |
70 days | 0%bb |
Gentile et al. 2010 | Retrospective | 33 | 22.8 | 11.3 (0.7) | 30 with NG+O; 3 with oral supplements and IV glucose | 1402 | 1895 by Day 7; 2212 by Day 15; 2510 by Day 30; 2683 by Day 45; 3000 by Day 60 | 0.63 | 60 | 0%cc |
Hatch et al. 2010 | Prospective (test-retest) | 37 | 15.1 | 16.1 (0.93)dd | 24-72 hr continuous NG only, then nighttime NG + meals to target weight gain rate 1 kg/week | 24-72 hr NG (100 ml/hr), then NG + 1200-1400 meals | Variable, to attain 2400-3000 kcal/day | NR | 2.5 wks | NR |
Gentile et al. 2012 | Retrospective | 10 | 23.9 | 11.2 (0.7) | Concentrated continuous NG feed with IV glucose for 24 hr and oral intake, started at 1199 kcal increase to 2871 by day 90 | 1199 | 2508 by day 15; 2784 by day 30; 2935 by day 60; 2871 by day 90 | 1.30 | 90 | 0%ee |
Agostino et al. 2013 | Retrospective | 31 NG+O 134 O |
14.9 | 16.6 (2.2) NG+O 16.7 (2.3) O |
Compare continuous NG transitioning to oral alone to oral alone (historical controls) | 1500-1800 NG+O 1000-1200 O |
200 | 0.66 L 0.92 H |
50.9 (24) L 33.8 (11) H |
3.6%ff |
Madden et al. 2015 | Prospective cohort |
78 | 14.8 | 24-72 hr continuous NG only, then nighttime NG + meals to target 2400-3000 kcals/day | 72 hr NG (100 ml/hr), then NG + 1200-1400 meals | Variable, to attain 2400-3000 kcal/day | 2.79 (wk 1) 1.34 (over 2.5 wk) |
28.6 | 0%gg | |
Combined total parenteral nutrition with oral intake | ||||||||||
Diamanti et al. 2008 | Retrospective | 104 PNhh+O 94 O |
14.9 PN+O 15.2 O |
14.3 (0.2) PN+O 16.0 (0.2) O |
Compare oral to oral+TPN; both groups start 40 kcal/kg/d for 5 d then increase to 60 kcal/kg/d over 1 week | 40 kcal/kg/day | Target 60 kcal/kg/day at day 7 | 0.71 PN+O 0.53 O |
30.7 (2.2) PN+O 15.6 (1.0) O |
3.8% (PN+O only) |
Altered nutrient content | ||||||||||
Rigaud et al. 2010 | Retrospective | 42 Nii 176 L |
22.1 N 23.3 L |
13.8 (1.7) N 13.2 (1.2) L |
Compare normal (4000-4800mg) vs. low (1600-2000 mg) Na diet. Both groups got NG+O feeding. | Ad lib except for Na | Ad lib except for Na | 1.09 L; N was NR | 2 months | NR |
For studies that included comparison groups, we report Ns separately for low-weight-gain (L) and high-weight-gain (H) interventions.
Age is presented as mean
BMI=body mass index (kg/m2).
Rates of caloric advancement are calculated for some programs, who may not advance calories every day.
In some cases these rates are calculated rather than derived directly from the published reports, and not all patients stayed at least a week in all studies.
IP LOS=inpatient length of stay.
RH=refeeding hypophosphatemia.
A and B refer to differing behavioral contracts (all participants started on same range of calories).
NR=not reported.
Per text, “daily calorie intake was increased only following agreement between the therapist and the patient.” (p 56)
Mean (SD) percent of ideal body weight was 72.7% (7.1).
Mean (SD) percent of ideal body weight was 72.9% (9.1).
Over the first two weeks of admission.
Mean (SD) percent median BMI was 80.1 (11.5).
Mean (SD) percent ideal body weight was 62% (10).
For studies that included comparison groups, Ns are reported separately for low-calorie (L) and high-calorie (H) interventions.
Mean (SD) percent median BMI was 77.6 (2.6) in the lower calorie group, 81.9 (1.8) in the higher calorie group.
Mean (SD) percent median BMI was 77.9 (9.6) in the lower calorie group, 78.7 (7.8) in the higher calorie group.
Mean (SD) percent ideal body weight was 75.8% (5.4).
Weight gain goal was 0.45-0.68 kg/wk
Program included 13 weeks inpatient treatment plus 7 weeks partial hospitalization.
Mean (SD) body weight was 34.51 (4.48) kg.
REE=resting energy expenditure.
Patients were discharged from the program to outpatient follow-up when they requested to switch back from enteral to meal-based refeeding and could demonstrate they had “food intake exceeding the basal metabolic rate” (p 405).
NG=nasogastric refeeding; O=oral refeeding.
“There were no cases of refeeding syndrome.” (p 417)
REE=resting energy expenditure.
Patients with BMI < 12 received prophylactic phosphorous supplementation.
Most patients received prophylactic phosphorous supplementation.
Mean (SD) percent ideal body weight was 79.1% (5.8).
Patients received prophylactic phosphorous supplementation.
All 6 patients with hypophosphatemia were in the oral-only group; however, 90.3% of patients in the enteral feeding group were on prophylactic phosphorous supplementation.
Patients received prophylactic phosphorous supplementation.
PN=parenteral nutrition; O=oral.
N=Normal sodium diet; L=low sodium diet.